These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Proper use of drugs. Intravenous administration and catheters]. Thalamy B; Woronoff-Lemsi MC; Belon JP Soins; 2000; (642):55-6. PubMed ID: 11075211 [No Abstract] [Full Text] [Related]
8. Guidelines for the clinical evaluation of antianxiety drugs. HEW (FDA) 77-3043, September 1977. Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):297-312. PubMed ID: 45205 [No Abstract] [Full Text] [Related]
9. New England Deaconess guidelines for the administration of i.v. drugs. Sesin P; Wiggins MS NITA; 1987; 10(3):224-34. PubMed ID: 3648519 [No Abstract] [Full Text] [Related]
10. Experimental drugs: where do you stand legally? Marchette L RN; 1984 Mar; 47(3):23-4. PubMed ID: 6366999 [No Abstract] [Full Text] [Related]
11. Clinical implications of i.v. drug administration in infants and children. Jew RK; Gordin P; Lengetti E Crit Care Nurse; 1997 Aug; 17(4):62-70. PubMed ID: 9325774 [No Abstract] [Full Text] [Related]
12. Development of medicines for children in Europe: ethical implications. Saint Raymond A; Brasseur D Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816 [TBL] [Abstract][Full Text] [Related]
13. Ethical implications of pediatric drug research policy initiatives. Twomey JG IRB; 2000; 22(2):5-10. PubMed ID: 11883466 [No Abstract] [Full Text] [Related]
20. New drugs: to use or not to use. Pepper GA Nurse Pract; 1985 Feb; 10(2):37, 41-2. PubMed ID: 3883249 [No Abstract] [Full Text] [Related] [Next] [New Search]